Australia markets open in 4 hours 5 minutes

Jeil Pharmaceutical Co.,Ltd (271980.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
15,190.000.00 (0.00%)
At close: 03:30PM KST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-10,575,627
5,004,745
-13,090,894
-12,473,279
6,916,121
-
Depreciation & amortisation
-
9,767,100
8,886,235
9,132,602
8,992,862
-
Stock-based compensation
-
578,027
472,480
163,169
80,042
-
Change in working capital
-
-20,688,837
-15,155,225
14,617,072
-39,787,710
-
Inventory
-
-10,574,679
3,562,010
6,334,108
-26,617,624
-
Other working capital
-
-14,556,539
-32,105,180
13,707,609
-21,913,038
-
Other non-cash items
-
4,996,508
2,893,484
1,702,606
1,327,312
-
Net cash provided by operating activities
-
-4,980,678
-15,146,990
19,100,246
-19,046,087
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-9,575,861
-16,958,190
-5,392,637
-2,866,951
-
Acquisitions, net
-
-
-
-3,000,000
-
-
Purchases of investments
-
-5,555,310
-300,939
0
-3,540,246
-
Sales/maturities of investments
-
3,031,111
2,198,543
654,526
28,236
-
Other investing activities
-
51,009
126,464
60,950
183,767
-
Net cash used for investing activities
-
-11,918,615
-12,924,122
-8,037,159
-5,576,976
-
Net change in cash
-
1,544,652
5,482,955
22,069,805
-9,621,797
-
Cash at beginning of period
-
31,446,234
25,963,279
3,893,474
13,515,271
-
Cash at end of period
-
32,990,886
31,446,234
25,963,279
3,893,474
-
Free cash flow
Operating cash flow
-
-4,980,678
-15,146,990
19,100,246
-19,046,087
-
Capital expenditure
-
-9,575,861
-16,958,190
-5,392,637
-2,866,951
-
Free cash flow
-
-14,556,539
-32,105,180
13,707,609
-21,913,038
-